Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction - Report - MDSpire

Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction

  • By

  • Yamin Xu

  • Xiabing Hu

  • Yun Qian

  • Hong Ding

  • Zhen Li

  • Xiuyu Ma

  • Pingzhen Wu

  • June 25, 2026

  • 0 min

Share

Link Between Remnant Cholesterol Inflammatory Index and New-Onset Atrial Fibrillation During Hospitalization in ST-Segment Elevation Myocardial Infarction Patients

Overview

This study investigates the association between the remnant cholesterol inflammatory index (RCII) and new-onset atrial fibrillation (NOAF) in patients with ST-segment elevation myocardial infarction (STEMI).

Background

New-onset atrial fibrillation is a frequent complication in patients hospitalized for STEMI, linked to worse clinical outcomes. Identifying patients at high risk for NOAF is crucial for improving monitoring and treatment strategies. The remnant cholesterol inflammatory index (RCII) combines lipid and inflammatory markers.

Data Highlights

ParameterValue
Patients with NOAF79 (8.36%)
RCII AUC0.756 (95% CI: 0.698–0.814)
hs-CRP OR2.96 (95% CI: 1.72–5.08, P < 0.001)
RCII OR4.71 (95% CI: 2.86–7.78, P < 0.001)
RC OR2.78 (95% CI: 1.88–4.10, P < 0.001)

Key Findings

  • 8.36% of STEMI patients developed new-onset atrial fibrillation during hospitalization.
  • Patients with NOAF had significantly higher levels of RCII, RC, and hs-CRP compared to those without NOAF.
  • RCII was independently associated with NOAF, with an odds ratio of 4.71.
  • hs-CRP and RC were also independently associated with NOAF, with odds ratios of 2.96 and 2.78, respectively.
  • RCII demonstrated moderate discriminatory ability for identifying NOAF with an AUC of 0.756.

Clinical Implications

The findings suggest that monitoring RCII levels could help healthcare professionals identify patients at risk for NOAF during hospitalization.

Conclusion

The study indicates that RCII is associated with in-hospital NOAF in STEMI patients.

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- The association of remnant cholesterol inflammatory index with the risk of major adverse cardiovascular events in patients with angina undergoing percutaneous coronary intervention: a retrospective study
  2. Frontiers in Cardiovascular Medicine, 2026 -- Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation
  3. Clinical Research in Cardiology -- Association of Plasma Interleukin 6 Concentrations with Cardiac Function Following ST-Elevation Myocardial Infarction
  4. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - American College of Cardiology
  5. Clinical Research in Cardiology — The Relationship Between Inflammation and Atrial High-Rate Episodes in Patients with Cardiac Implantable Devices
  6. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - American College of Cardiology
  7. Incremental prognostic value of left atrial reservoir strain after ST-segment elevation myocardial infarction for the prediction of new-onset atrial fibrillation | The International Journal of Cardiovascular Imaging | Springer Nature Link
  8. Cumulative average remnant cholesterol inflammatory index and risk of cardiometabolic multimorbidity: evidence from a prospective nationwide cohort study in China - PubMed

Original Source(s)

Related Content